Urinary aprotinin as a predictor of acute kidney injury after cardiac surgery in children receiving aprotinin therapy

[1]  John T Granton,et al.  Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. , 2007, JAMA.

[2]  M. Okusa,et al.  Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon. , 2007, Clinical journal of the American Society of Nephrology : CJASN.

[3]  A. Hoeft,et al.  Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. , 2007, JAMA.

[4]  K. Weiss,et al.  Judging the safety of aprotinin. , 2006, The New England journal of medicine.

[5]  Sean M. O'Brien,et al.  Bedside Tool for Predicting the Risk of Postoperative Dialysis in Patients Undergoing Cardiac Surgery , 2006, Circulation.

[6]  P. Devarajan.  Update on mechanisms of ischemic acute kidney injury. , 2006, Journal of the American Society of Nephrology : JASN.

[7]  R. Vaughan,et al.  Influence of donor C3 allotype on late renal-transplantation outcome. , 2006, The New England journal of medicine.

[8]  J. Ramsay,et al.  Aprotinin in cardiac surgery. , 2006, The New England journal of medicine.

[9]  N. Birkmeyer,et al.  Aprotinin in cardiac surgery. , 2006, New England Journal of Medicine.

[10]  M. D'ambra,et al.  Aprotinin in cardiac surgery. , 2006, New England Journal of Medicine.

[11]  Keyvan Karkouti,et al.  A propensity score case‐control comparison of aprotinin and tranexamic acid in high‐transfusion‐risk cardiac surgery , 2006, Transfusion.

[12]  F. Sellke,et al.  Aprotinin in cardiac surgery , 2006, Expert review of cardiovascular therapy.

[13]  D. Hunter,et al.  First, gather the data. , 2006, The New England journal of medicine.

[14]  G. Vlahakes.  The value of phase 4 clinical testing. , 2006, New England Journal of Medicine.

[15]  I. C. Tudor,et al.  The risk associated with aprotinin in cardiac surgery. , 2006, The New England journal of medicine.

[16]  M. Okusa,et al.  Acute kidney injury associated with cardiac surgery. , 2005, Clinical journal of the American Society of Nephrology : CJASN.

[17]  J. Campistol,et al.  Kidney‐specific proteins in patients receiving aprotinin at high‐ and low‐dose regimens during coronary artery bypass graft with cardiopulmonary bypass , 2005, European journal of anaesthesiology.

[18]  G. Ross,et al.  Early Prediction of Acute Renal Injury Using Urinary Proteomics , 2005, American Journal of Nephrology.

[19]  Qing Ma,et al.  Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery , 2005, The Lancet.

[20]  S. Arrigain,et al.  Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function. , 2005, Kidney international.

[21]  R. Henning,et al.  Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. , 2004, Journal of the American Society of Nephrology : JASN.

[22]  R. Mehta.  Acute renal failure and cardiac surgery: marching in place or moving ahead? , 2004, Journal of the American Society of Nephrology : JASN.

[23]  S. Arrigain,et al.  A clinical score to predict acute renal failure after cardiac surgery. , 2004, Journal of the American Society of Nephrology : JASN.

[24]  T. Treasure,et al.  Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: a systematic review and meta-analysis of randomized clinical trials. , 2004, The Journal of thoracic and cardiovascular surgery.

[25]  P. Austin,et al.  Impact of renal insufficiency on short- and long-term outcomes after cardiac surgery. , 2004, American heart journal.

[26]  L. Bachmann,et al.  Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. , 2004, Journal of the American Society of Nephrology : JASN.

[27]  L. Cohn,et al.  Cardiac Surgery in the Adult , 2003 .

[28]  R. Cardigan,et al.  Determination of plasma aprotinin levels by functional and immunologic assays , 2001, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[29]  C. Fraser,et al.  Early initiation of peritoneal dialysis after surgical repair of congenital heart disease , 1999, Pediatric Nephrology.

[30]  K E Hammermeister,et al.  Independent association between acute renal failure and mortality following cardiac surgery. , 1998, The American journal of medicine.

[31]  D. Mangano,et al.  Renal Dysfunction after Myocardial Revascularization: Risk Factors, Adverse Outcomes, and Hospital Resource Utilization , 1998, Annals of Internal Medicine.

[32]  R. Bartlett,et al.  Outcome-associated factors in pediatric patients treated with extracorporeal membrane oxygenator after cardiac surgery. , 1996, Circulation.

[33]  J. Mayer,et al.  Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. , 1995, Circulation.

[34]  D. Royston,et al.  Aprotinin; friend or foe? A review of recent medical literature. , 2007, European journal of anaesthesiology.

[35]  P. Devarajan.  Emerging biomarkers of acute kidney injury. , 2007, Contributions to nephrology.

[36]  R. Bellomo,et al.  Cardiopulmonary bypass-associated acute kidney injury: a pigment nephropathy? , 2007, Contributions to nephrology.

[37]  N. Birkmeyer,et al.  To the editor [8] , 2006 .

[38]  L. Edmunds,et al.  Hessel EA II, Edmunds LH Jr. Extracorporeal Circulation: Perfusion Systems. In: Cohn LH, Edmunds LH Jr, eds. Cardiac Surgery in the Adult. New York: McGraw-Hill, 2003:317338. , 2003 .

[39]  Kimberlee Gauvreau,et al.  Consensus-based method for risk adjustment for surgery for congenital heart disease. , 2002, The Journal of thoracic and cardiovascular surgery.